HighField Biopharmaceuticals Corporation
HighField Biopharmaceuticals Corporation
Explore linked clinical trials.4 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Activity of HF50 in Patients With Advanced Solid Tumors | Advanced Solid Tumors | Recruiting | Phase 1 | 2026-09-28 | NCT07601334 | |
| A Study of HF1K16 Combined With Bevacizumab in Patients With Recurrent or Progressive Glioma | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, epithelial neoplasm, glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor | Recruiting | Phase 2 | 2026-07-10 | NCT07678684 | |
| HF158K1 in Patients With HER-2 Expressing Advanced Solid Tumors | Solid Tumors, Adult | Recruiting | Phase 1 | 2026-06-26 | NCT05861895 | |
| HF50 in HER-2 Positive and Low-expression Advanced Solid Tumors | Advanced Solid Tumors | Recruiting | Early phase 1 | 2025-08-17 | NCT06822998 |